Catherine H. Régnier

5.0k total citations · 2 hit papers
46 papers, 3.7k citations indexed

About

Catherine H. Régnier is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Catherine H. Régnier has authored 46 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Catherine H. Régnier's work include NF-κB Signaling Pathways (11 papers), interferon and immune responses (8 papers) and Immune Response and Inflammation (6 papers). Catherine H. Régnier is often cited by papers focused on NF-κB Signaling Pathways (11 papers), interferon and immune responses (8 papers) and Immune Response and Inflammation (6 papers). Catherine H. Régnier collaborates with scholars based in France, Switzerland and United States. Catherine H. Régnier's co-authors include David V. Goeddel, Mike Rothe, Ho Yeong Song, Xiong Gao, Zhaodan Cao, Catherine Tomasetto, Christel Moog‐Lutz, Paul Basset, Carsten J. Kirschning and Corinne Wendling and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Catherine H. Régnier

43 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Characterization of an IκB Kinase

1997 1.1k citations Catherine H. Régnier, Ho Yeong Song et al. Cell profile →
Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of Nuclear Factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

1997 500 citations Ho Yeong Song, Catherine H. Régnier et al. profile →

Peers

Countries citing papers authored by Catherine H. Régnier

Since Specialization

Citations

This map shows the geographic impact of Catherine H. Régnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine H. Régnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine H. Régnier more than expected).

Fields of papers citing papers by Catherine H. Régnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine H. Régnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine H. Régnier. The network helps show where Catherine H. Régnier may publish in the future.

Co-authorship network of co-authors of Catherine H. Régnier

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine H. Régnier. A scholar is included among the top collaborators of Catherine H. Régnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine H. Régnier. Catherine H. Régnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells 2025 ·Clinical & Experimental Immunology ·(unknown), Jens Wittner, Christian H.K. Lehmann, Mandy Wahlbuhl, (unknown), (unknown), (unknown), (unknown), Holger Hackstein, (unknown), James S. Rush, Catherine H. Régnier, Hans‐Martin Jäck, Joachim Woelfle, (unknown), André Hoerning	0
2	Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality 2023 ·Journal of Clinical Investigation ·Tiffany Shi, Ashley R. Burg, J. Timothy Caldwell, Krishna M. Roskin, (unknown), (unknown), (unknown), (unknown), Jesus A. Alonso, Carla M. Cuda, David Allman, James S. Rush, Catherine H. Régnier, Grazyna Wieczorek, Rita R. Alloway, Adele R. Shields, Brian M. Baker, E. Steve Woodle, David A. Hildeman	22
3	N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity 2018 ·Bioorganic & Medicinal Chemistry Letters ·Achim Schlapbach, Láśzló Révész, Carole Pissot‐Soldermann, Thomas Zöller, Catherine H. Régnier, Frédéric Bornancin, Thomas Radimerski, Jutta Blank, Ansgar Schuffenhauer, Martin Renatus, P. Erbel, Samu Melkko, Richard Heng, Oliver Simić, (unknown), Markus Wartmann, Jean Quancard	18
4	Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation 2017 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Florian Renner, Stephen T.S. Lam, Felix Freuler, Bertran Gerrits, Johannes Voshol, Thomas Calzascia, Catherine H. Régnier, Martin Renatus, Rainer Nikolay, Laura Israël, Frédéric Bornancin	19
5	The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling 2015 ·Nature Communications ·Théo Klein, Shan‐Yu Fung, Florian Renner, Michael A. Blank, Antoine Dufour, Sohyeong Kang, Madison Bolger-Munro, Joshua Scurll, John J. Priatel, (unknown), Samu Melkko, Michael R. Gold, Rosa Viner, Catherine H. Régnier, Stuart E. Turvey, Christopher M. Overall	122
6	2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Marc Gerspacher, Pascal Furet, Carole Pissot‐Soldermann, Christoph Gaul, Philipp Holzer, Eric Vangrevelinghe, Marc Lang, Dirk Erdmann, Thomas Radimerski, Catherine H. Régnier, Patrick Chêne, Alain De Pover, Francesco Hofmann, Fabienne Baffert, Thomas Buhl, Reiner Aichholz, Francesca Blasco, (unknown), Jörg Trappe, Peter Drueckes	21
7	Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome 2009 ·Kidney International ·Frank Bienaimé, Marie‐Agnès Dragon‐Durey, Catherine H. Régnier, Sara C. Nilsson, W. H. Kwan, Jacques Blouin, Mathieu Jablonski, Nicolas Renault, Marie‐Anne Rameix‐Welti, Chantal Loirat, Catherine Sautès‐Fridman, Bruno O. Villoutreix, Anna M. Blom, Véronique Frémeaux‐Bacchi	140
8	Characterization of immune functions in TRAF4‐deficient mice 2008 ·Immunology ·Julien Cherfils‐Vicini, Benoît Vingert, Audrey Varin, Éric Tartour, Wolf H. Fridman, Catherine Sautès‐Fridman, Catherine H. Régnier, Isabelle Cremer	23
9	Hereditary complement C7 deficiency in nine families: Subtotal C7 deficiency revisited 2007 ·European Journal of Immunology ·Marie‐Anne Rameix‐Welti, Catherine H. Régnier, Frank Bienaimé, Jacques Blouin, Jürg A. Schifferli, Wolf H. Fridman, Catherine Sautès‐Fridman, Véronique Frémeaux‐Bacchi	26
10	Lasp-1, a Novel Type of Actin-Binding Protein Accumulating in Cell Membrane Extensions 1998 ·Molecular Medicine ·Valérie Schreiber, Christel Moog‐Lutz, Catherine H. Régnier, Marie‐Pierre Chenard, Hélène Bœuf, Jean‐Luc Vonesch, Catherine Tomasetto, Marie‐Christine Rio	82
11	Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development 1998 ·Mechanisms of Development ·Régis Masson, Catherine H. Régnier, Marie‐Pierre Chenard, Corinne Wendling, Marie‐Geneviève Mattéi, Catherine Tomasetto, Marie–Christine Rio	43
12	Expression of a truncated form of hHb1 hair keratin in human breast carcinomas 1998 ·British Journal of Cancer ·Catherine H. Régnier, Anne Boulay, (unknown), Corinne Wendling, M-P Chenard, Catherine Tomasetto, MC Rio	12
13	Expression pattern of human hair keratin basic 1 (hHbl) in hair follicle and pilomatricoma 1997 ·Experimental Dermatology ·Catherine H. Régnier, (unknown), E Grosshans, Marie‐Christine Rio	6
14	Identification and Characterization of an IκB Kinase breakdown → 1997 ·Cell ·Catherine H. Régnier, Ho Yeong Song, Xiong Gao, David V. Goeddel, Zhaodan Cao, Mike Rothe	1055
15	MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas 1997 ·International Journal of Cancer ·Christel Moog‐Lutz, Catherine Tomasetto, Catherine H. Régnier, Corinne Wendling, Yves Lutz, Danièle Muller, (unknown), Paul Basset, Marie–Christine Rio	114
16	Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. 1996 ·PubMed ·Ivan Bièche, Catherine Tomasetto, Catherine H. Régnier, Christel Moog‐Lutz, Marie‐Christine Rio, Rosette Lidereau	89
17	Lasp‐1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains 1995 ·FEBS Letters ·Catherine Tomasetto, Christel Moog‐Lutz, Catherine H. Régnier, Valérie Schreiber, Paul Basset, Marie–Christine Rio	127
18	Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma 1995 ·Journal of Biological Chemistry ·Catherine H. Régnier, Catherine Tomasetto, Christel Moog‐Lutz, Marie-Pierre Chenard, Corinne Wendling, Paul Basset, Marie‐Christine Rio	206
19	Identification of Four Novel Human Genes Amplified and Overexpressed in Breast Carcinoma and Localized to the q11-q21.3 Region of Chromosome 17 1995 ·Genomics ·Catherine Tomasetto, Catherine H. Régnier, Christel Moog‐Lutz, Marie‐Geneviève Mattéi, (unknown), Rosette Lidereau, Paul Basset, M. C. Rio	220
20	[Prostatic cancer in the 19th century]. 1994 ·PubMed ·Catherine H. Régnier	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact